Literature DB >> 3509834

Trends in stroke mortality and in antihypertensive treatment in Finland from 1972 to 1984 with special reference to North Karelia.

J Tuomilehto1, T Piha, A Nissinen, J Geboers, P Puska.   

Abstract

Trends in antihypertensive treatment and stroke mortality were analysed in the province of North Karelia where the first systematic hypertension control programme in Finland was started in 1972. Surveys carried out in random samples of the middle-aged population of North Karelia showed that the control of hypertension was better than in the reference area, especially from 1972 to 1977. From 1972 to 1984, mortality from stroke fell on average 6.3% and 7.6% per annum, in North Karelian men and women aged 35-64 years. These declines were steeper than those observed in the rest of Finland. In the age group of 65-74 years the decline in stroke mortality was also steeper in North Karelia. From 1978 to 1984 the self-reported awareness of hypertension and the proportion of people receiving antihypertensive drug treatment decreased in the middle-aged population in Finland, suggesting lesser efforts at detection and treatment. During the same period, the steep national decline in stroke mortality levelled off, but the mortality rate remained higher than in the USA and in other Western European countries. Prevention of stroke through hypertension control in the community still remains a major challenge for health care.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3509834

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  2 in total

1.  Do changes in cardiovascular risk factors explain changes in mortality from stroke in Finland?

Authors:  E Vartiainen; C Sarti; J Tuomilehto; K Kuulasmaa
Journal:  BMJ       Date:  1995-04-08

2.  Prioritizing Community-Based Intervention Programs for Improving Treatment Compliance of Patients with Chronic Diseases: Applying an Analytic Hierarchy Process.

Authors:  Do Hwa Byun; Rho Soon Chang; Myung-Bae Park; Hyo-Rim Son; Chun-Bae Kim
Journal:  Int J Environ Res Public Health       Date:  2021-01-08       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.